Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ontaneda

Showing results (71-80 of 193) with videos related to

Pageof 20
Sort By:
The Lancet. Neurology|May 13, 2026
Flip angle in susceptibility-weighted imaging for the diagnosis of multiple sclerosis - Authors' replyPascal Sati, Frederik Barkhof, Daniel S Reich, et al.
Neurologic Clinics|November 18, 2023
Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis: What Is the Future of Multiple Sclerosis Treatment?Nicole Bou Rjeily, Ellen M Mowry, Daniel Ontaneda, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 7, 2017
Smokers with MS have greater decrements in quality of life and disability than non-smokersFarren Bs Briggs, Douglas D Gunzler, Daniel Ontaneda, et al.
Lancet (London, England)|November 28, 2016
Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of functionDaniel Ontaneda, Alan J Thompson, Robert J Fox, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|September 14, 2025
Association of Spinal Cord Radiomic Features and Disability in Multiple SclerosisJeffrey Lambe, Nicolas R Thompson, Yadi Li, et al.
Neuroepidemiology|March 12, 2024
Incidence of Multiple Sclerosis in Uruguay: A Prospective Population-Based StudyValeria Rocha, Noelia Sorondo, Fabián Gómez, et al.
Multiple Sclerosis and Related Disorders|July 4, 2021
Is computerized screening for processing speed impairment sufficient for identifying MS-related cognitive impairment in a clinical setting?Rachel Galioto, Gabrielle Macaron, John W Lace, et al.
Neurology|January 2, 2024
Geographic Disparities in Access to Neurologists and Multiple Sclerosis Care in the United StatesMarisa P McGinley, Tucker Harvey, Rocio Lopez, et al.
International Journal of MS Care|May 20, 2024
Association Between Disease-Modifying Therapy and Information Processing Speed in Multiple SclerosisAlbert Aboseif, Moein Amin, James Bena, et al.
Neurology|August 31, 2016
Natalizumab-related PML 2 weeks after negative anti-JCV antibody assayDaniel Ontaneda, Robert J Fox, Marie-Sarah Gagne Brosseau, et al.
Pageof 20

Showing results (71-80 of 193) with videos related to

Sort By:
Pageof 20
The Lancet. Neurology|May 13, 2026
Flip angle in susceptibility-weighted imaging for the diagnosis of multiple sclerosis - Authors' replyPascal Sati, Frederik Barkhof, Daniel S Reich, et al.
Neurologic Clinics|November 18, 2023
Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis: What Is the Future of Multiple Sclerosis Treatment?Nicole Bou Rjeily, Ellen M Mowry, Daniel Ontaneda, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 7, 2017
Smokers with MS have greater decrements in quality of life and disability than non-smokersFarren Bs Briggs, Douglas D Gunzler, Daniel Ontaneda, et al.
Lancet (London, England)|November 28, 2016
Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of functionDaniel Ontaneda, Alan J Thompson, Robert J Fox, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|September 14, 2025
Association of Spinal Cord Radiomic Features and Disability in Multiple SclerosisJeffrey Lambe, Nicolas R Thompson, Yadi Li, et al.
Neuroepidemiology|March 12, 2024
Incidence of Multiple Sclerosis in Uruguay: A Prospective Population-Based StudyValeria Rocha, Noelia Sorondo, Fabián Gómez, et al.
Multiple Sclerosis and Related Disorders|July 4, 2021
Is computerized screening for processing speed impairment sufficient for identifying MS-related cognitive impairment in a clinical setting?Rachel Galioto, Gabrielle Macaron, John W Lace, et al.
Neurology|January 2, 2024
Geographic Disparities in Access to Neurologists and Multiple Sclerosis Care in the United StatesMarisa P McGinley, Tucker Harvey, Rocio Lopez, et al.
International Journal of MS Care|May 20, 2024
Association Between Disease-Modifying Therapy and Information Processing Speed in Multiple SclerosisAlbert Aboseif, Moein Amin, James Bena, et al.
Neurology|August 31, 2016
Natalizumab-related PML 2 weeks after negative anti-JCV antibody assayDaniel Ontaneda, Robert J Fox, Marie-Sarah Gagne Brosseau, et al.
Pageof 20